CIK 0001426800 · Non-accelerated filer<br>Smaller reporting company
ASSEMBLY BIOSCIENCES, INC.
Sign in to watch- Ticker
- ASMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (833) 409-4583
- Business address
- TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- VENTRUS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $237,648
- in 4 filings
Net −$237,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-07-10 | RINGO WILLIAM R Director | Grant or award · Stock Option (right to buy) | +64,000 | 64,000 | ||
| 2014-07-10 | AUERBACH MARK Director | Grant or award · Stock Options (right to buy) | +64,000 | 64,000 | ||
| 2014-07-10 | HOLUBIAK MYRON Z Director | Grant or award · Stock Options (right to buy) | +64,000 | 64,000 | ||
| 2014-07-10 | ALTIG ANTHONY E Director | Grant or award · Stock Options (Right to Buy) | +64,000 | 64,000 | ||
| 2014-07-10 | Lopatin Uri A Chief Med. Off., VP Res. Dev. | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2014-07-10 | ELLISON RUSSELL H Chief Executive Officer | Grant or award · Stock Options (right to buy) | +800,000 | 800,000 | ||
| 2014-07-10 | BARRETT DAVID JONATHAN Chief Financial Officer | Grant or award · Stock Options (right to buy) | +741,800 | 741,800 | ||
| 2014-07-10 | Zlotnick Adam 10% owner | Grant or award · Stock Option (right to buy) | +128,000 | 128,000 | ||
| 2014-07-10 | RINGO WILLIAM R Director | Grant or award · Stock Option (right to buy) | +64,000 | 64,000 | ||
| 2014-07-10 | Lopatin Uri A Chief Med. Off., VP Res. Dev. | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2014-07-10 | DiMarchi Richard D Director | Grant or award · Stock Option (right to buy) | +64,000 | 64,000 | ||
| 2014-07-10 | ELLISON RUSSELL H Chief Executive Officer | Grant or award · Stock Options (right to buy) | +741,800 | 741,800 | ||
| 2014-07-10 | ELLISON RUSSELL H Chief Executive Officer | Returned to the company · Stock Options (right to buy) | −79,100 | 0 | ||
| 2014-07-10 | ELLISON RUSSELL H Chief Executive Officer | Returned to the company · Restricted Stock Units | −40,000 | 0 | ||
| 2014-07-10 | ELLISON RUSSELL H Chief Executive Officer | Returned to the company · Phantom Stock | −10,000 | 0 | ||
| 2014-07-10 | ELLISON RUSSELL H Chief Executive Officer | Returned to the company · Stock Options (right to buy) | −12,000 | 0 | ||
| 2014-07-10 | ELLISON RUSSELL H Chief Executive Officer | Returned to the company · Stock Options (right to buy) | −114,719 | 0 | ||
| 2014-07-10 | ALTIG ANTHONY E Director | Grant or award · Stock Options (Right to Buy) | +64,000 | 64,000 | ||
| 2014-07-10 | ALTIG ANTHONY E Director | Returned to the company · Stock Options (Right to Buy) | +7,000 | 0 | ||
| 2014-07-10 | HOLUBIAK MYRON Z Director | Grant or award · Stock Options (right to buy) | +64,000 | 64,000 |
Page 19 of 22 · 434 trades